Provided by Tiger Fintech (Singapore) Pte. Ltd.

Affimed NV

0.7335
+0.00751.03%
Post-market: 0.73370.0002+0.03%19:11 EDT
Volume:15.45K
Turnover:11.30K
Market Cap:12.02M
PE:-0.14
High:0.7487
Open:0.7487
Low:0.7201
Close:0.7260
Loading ...

Affimed NV expected to post a loss of 81 cents a share - Earnings Preview

Reuters
·
Yesterday

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
27 Mar

Affimed Announces Acceptance of AFM24 Abstract on Dose Optimization for Presentation at American Association for Cancer Research Annual Meeting

GlobeNewswire
·
26 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
24 Mar

Affimed NV expected to post a loss of 81 cents a share - Earnings Preview

Reuters
·
21 Mar

Affimed (AFMD) Gets a Buy from Truist Financial

TIPRANKS
·
18 Dec 2024

Affimed Nv : H.c. Wainwright Cuts Target Price to $7 From $10

THOMSON REUTERS
·
18 Dec 2024

Analysts Offer Insights on Healthcare Companies: Affimed (AFMD) and Ardent Health Partners, Inc. (ARDT)

TIPRANKS
·
18 Dec 2024

Affimed Shares Fall 32% on Clinical Update

GuruFocus.com
·
18 Dec 2024

Affimed’s AFM24/atezolizumab combination shows positive results in NSCLC trial

TIPRANKS
·
17 Dec 2024

Analysts Offer Insights on Healthcare Companies: Affimed (AFMD), Editas Medicine (EDIT) and Trevi Therapeutics (TRVI)

TIPRANKS
·
16 Dec 2024

Affimed Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
10 Dec 2024

Affimed Reports Efficacy, Safety Data From Leukemia Treatment Study

MT Newswires Live
·
10 Dec 2024

Affimed reports ‘promising’ Phase 1 efficacy, safety data for AFM28

TIPRANKS
·
10 Dec 2024

Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients

GlobeNewswire
·
09 Dec 2024

AFMD Stock Down Despite FDA's RMAT Status for Lymphoma Therapy

Zacks
·
06 Dec 2024

Affimed: Acimtamig, AlloNK combination granted RMAT designation by FDA

TIPRANKS
·
05 Dec 2024

Is Affimed N.V. (AFMD) the Best German Stock to Buy Now?

Insider Monkey
·
20 Nov 2024

Affimed Nv : Stifel Cuts Target Price to $4 From $5

THOMSON REUTERS
·
15 Nov 2024

Affimed Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
15 Nov 2024